Antioxidant Urate Fails to Slow Early Disease Progression

Antioxidant Urate Fails to Slow Early Disease Progression

306180

Antioxidant Urate Fails to Slow Early Disease Progression

The antioxidant urate failed to slow Parkinson’s disease progression in newly diagnosed patients over two years, according to data from a Phase 3 clinical trial. “While our study did not rule out a protective effect of urate in Parkinson’s, it clearly showed that increasing urate did not slow disease progression based on clinical assessments and serial bran scan biomarkers of neurodegeneration,” Michael Schwarzschild, MD, PhD, said in a MGH press release. Schwarzschild is a neurologist…

You must be logged in to read/download the full post.